Proteomics Identifies TRAP5 as a Candidate Marker of Residual Inflammation After Optimal Pulse Technology in Experimental Meibomian Gland Dysfunction

Yang Lu, Lan Gong

Open source

DOI
10.1167/iovs.67.13.4
Published
2026-11-02
Container
Investigative Ophthalmology & Visual Science
Publisher
Association for Research in Vision and Ophthalmology (ARVO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1167/iovs.67.13.4,
  title = {Proteomics Identifies TRAP5 as a Candidate Marker of Residual Inflammation After Optimal Pulse Technology in Experimental Meibomian Gland Dysfunction},
  author = {Yang Lu and Lan Gong},
  year = {2026},
  journal = {Investigative Ophthalmology \& Visual Science},
  doi = {10.1167/iovs.67.13.4},
  url = {https://doi.org/10.1167/iovs.67.13.4}
}

RIS

TY  - JOUR
TI  - Proteomics Identifies TRAP5 as a Candidate Marker of Residual Inflammation After Optimal Pulse Technology in Experimental Meibomian Gland Dysfunction
AU  - Yang Lu
AU  - Lan Gong
PY  - 2026
JO  - Investigative Ophthalmology & Visual Science
DO  - 10.1167/iovs.67.13.4
UR  - https://doi.org/10.1167/iovs.67.13.4
ER  - 

APA

Lu, Y., & Gong, L. (2026). Proteomics Identifies TRAP5 as a Candidate Marker of Residual Inflammation After Optimal Pulse Technology in Experimental Meibomian Gland Dysfunction. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.13.4

Source records